Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Mimetogen Pharmaceuticals patents

List of Mimetogen Pharmaceuticals patents

List of Natel Energy patents

List of Balanced Body patents

List of Nalu Medical patents

List of SBIR/STTR awards granted to Professional Services Group

List of SBIR/STTR awards granted to Applied Research In Acoustics Llc

Patents where

Current Assignee

Name

is

‌

Mimetogen Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9707267 Beta-turn peptidomimetic cyclic compounds for treating dry eye	Patent 9707267 was granted and assigned to Mimetogen Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.	‌ Mimetogen Pharmaceuticals	‌ Mimetogen Pharmaceuticals		United States Patent and Trademark Office	9707267	July 18, 2017
	‌ US Patent 11078234 Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts	Patent 11078234 was granted and assigned to Mimetogen Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.	‌ Mimetogen Pharmaceuticals	‌ Mimetogen Pharmaceuticals		United States Patent and Trademark Office	11078234	August 3, 2021
	‌ US Patent 10125165 Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts	Patent 10125165 was granted and assigned to Mimetogen Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office.	‌ Mimetogen Pharmaceuticals	‌ Mimetogen Pharmaceuticals		United States Patent and Trademark Office	10125165	November 13, 2018
	‌ US Patent 8653036 Methods of treating retinitis pigmentosa	Patent 8653036 was granted and assigned to Mimetogen Pharmaceuticals on February, 2014 by the United States Patent and Trademark Office.		‌ Mimetogen Pharmaceuticals		United States Patent and Trademark Office	8653036	February 18, 2014
	‌ US Patent 9156882 Beta-turn peptidomimetic cyclic compounds for treating dry eye	Patent 9156882 was granted and assigned to Mimetogen Pharmaceuticals on October, 2015 by the United States Patent and Trademark Office.	‌ Mimetogen Pharmaceuticals	‌ Mimetogen Pharmaceuticals		United States Patent and Trademark Office	9156882	October 13, 2015
	‌ US Patent 9115179 Synthesis of beta-turn peptidomimetic cyclic compounds	Patent 9115179 was granted and assigned to Mimetogen Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.	‌ Mimetogen Pharmaceuticals	‌ Mimetogen Pharmaceuticals		United States Patent and Trademark Office	9115179	August 25, 2015
	‌ US Patent 8748391 β-turn peptidomimetic cyclic compounds for treating dry eye			‌ Mimetogen Pharmaceuticals		United States Patent and Trademark Office	8748391	June 10, 2014
	‌ US Patent 8293713 Beta-turn peptidomimetic cyclic compounds for treating dry eye	Patent 8293713 was granted and assigned to Mimetogen Pharmaceuticals on October, 2012 by the United States Patent and Trademark Office.		‌ Mimetogen Pharmaceuticals		United States Patent and Trademark Office	8293713	October 23, 2012
	‌ US Patent 11753441 Solution phase synthesis of beta-turn peptidomimetic cyclic salts	Patent 11753441 was granted and assigned to Mimetogen Pharmaceuticals on September, 2023 by the United States Patent and Trademark Office.	‌ Mimetogen Pharmaceuticals	‌ Mimetogen Pharmaceuticals		United States Patent and Trademark Office	11753441	September 12, 2023

9 results

0 selected

9 results

0 selected